Page 10 - Test PDF v5

« Back to Contents OVARIAN CANCER

LiFE re

Literature for ENYGO

Medical treatment of primary ovarian cancer

Relevant articles retrieved Nov 2015 - Feb 2016

No Title Authors Journal Link to abstract
Lancet Oncol.
1 Standard first-line chemotherapy with or without nintedanib for advanced du Bois A et al. http://www.ncbi.nlm.nih.gov/
pubmed/26590673
ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled

phase 3 trial.

2 Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. Chan JK et al. N Engl J Med. http://www.ncbi.nlm.nih.gov/
Ann Oncol. pubmed/26933849
3 Early initiation of chemotherapy following complete resection of advanced Tewari KS et al.
http://www.ncbi.nlm.nih.gov/
ovarian cancer associated with improved survival: NRG Oncology/Gynecologic pubmed/26487588

Oncology Group study.

4 A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy Bouchard-Fortier G Gynecol Oncol. http://www.ncbi.nlm.nih.gov/
Cochrane Database Syst Rev. pubmed/26546964
regimens for advanced-stage epithelial ovarian cancer. et al. Cochrane Database Syst Rev.
Gynecol Oncol. http://www.ncbi.nlm.nih.gov/
5 Intraperitoneal chemotherapy for the initial management of primary epithelial Jaaback K et al. Gynecol Oncol. pubmed/26755441
ovarian cancer. Tumour Biol.
Gynecol Oncol. http://www.ncbi.nlm.nih.gov/
6 Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Lawrie TA et al. pubmed/26676202

7 Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women Mahdi H et al. http://www.ncbi.nlm.nih.gov/
with advanced-stage Müllerian cancer. Grabowski JP et al. pubmed/26210778
Ruscito I et al.
8 Operability and chemotherapy responsiveness in advanced low-grade serous https://www.ncbi.nlm.nih.gov/
ovarian cancer. An analysis of the AGO Study Group metadatabase. pubmed/26807488

9 Cediranib in ovarian cancer: state of the art and future perspectives. http://www.ncbi.nlm.nih.gov/
pubmed/26753963
10 Chemotherapy in ovarian germ cell tumors: A systematic review. Simone CG et al.
http://www.ncbi.nlm.nih.gov/
pubmed/26873864

International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 10